These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model. Pavel STI, Yetiskin H, Kalkan A, Ozdarendeli A. PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988 [Abstract] [Full Text] [Related]
6. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus. Spengler JR, Patel JR, Chakrabarti AK, Zivcec M, García-Sastre A, Spiropoulou CF, Bergeron É. J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644 [Abstract] [Full Text] [Related]
7. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice. Hinkula J, Devignot S, Åkerström S, Karlberg H, Wattrang E, Bereczky S, Mousavi-Jazi M, Risinger C, Lindegren G, Vernersson C, Paweska J, van Vuren PJ, Blixt O, Brun A, Weber F, Mirazimi A. J Virol; 2017 May 15; 91(10):. PubMed ID: 28250124 [Abstract] [Full Text] [Related]